trending Market Intelligence /marketintelligence/en/news-insights/trending/oo5wksl2t3uaandttpx3xa2 content esgSubNav
In This List

TearLab CFO to resign; interim named

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


TearLab CFO to resign; interim named

TearLab Corp. said Wes Brazell will resign as CFO to pursue another professional opportunity, effective March 30.

The San Diego-based diagnostic company named Michael Marquez interim CFO. Marquez is TearLab's senior director of finance.

Brazell has been CFO of TearLab since July 2015.

The company's TearLab Osmolarity System is a diagnostic test that aids in the detection of dry eye disease in patients.